Indeed, knockdown of PML or treatment of glioblastoma cells with the PML degradation agent, arsenic trioxide, inhibited cancer stem cell growth as well as glioblastoma tumor growth in a mouse xenograft model [113]. The gene discussed is PML; the disease is neoplasm.